Multi-Chambered Heart Organoids Allow Study of Organ Development and Defects
Scientists at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences have developed a multi-chamber organoid that mirrors the heart’s intricate structure. The human cardioid platform recapitulates the development of all...
Understanding rapid tendon regeneration in newts may one day help human athletes
A research group led by Nagoya University’s Graduate School of Engineering has uncovered how rapid tendon regeneration occurs in newts. The research, published in the Journal of Orthopaedic Research, compared the regeneration mechanism of...
New heart organoid model could revolutionize drug development and toxicology studies
Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid that...
Nvidia Looks to Genentech for Its Next Leap in AI Drug Discovery
By Alex Philippidis
Nvidia, the Silicon Valley-based microprocessing giant, has expanded its growing footprint in artificial intelligence (AI)-based life sciences through the new AI drug discovery collaboration it has launched with Roche’s Genentech subsidiary.
The companies...
Five companies shaping Texas’ growing biotech hubs
Thanks to the U.S. government’s ambitious plans to advance American biotech and biomanufacturing, Texas’ life sciences hubs, particularly in Dallas and Houston, are now one of many in the country that are currently thriving....
Compact accelerator technology achieves major energy milestone
Particle accelerators hold great potential for semiconductor applications, medical imaging and therapy, and research in materials, energy and medicine. But conventional accelerators require plenty of elbow room — kilometers — making them expensive and...
Proteomics Platform Reduces Quantification to Counting
By Gail Dutton Despite their sophistication and power, traditional proteomics technologies have failed to provide comprehensive coverage. For example, with conventional mass spectrometry, a single experiment measures no more than 8% of the blood...
How are R&D Tax Incentives shaping Australia’s biotech future?
Research and development (R&D) stands as a cornerstone for driving innovation, particularly within the biotech industry. The pivotal role of R&D extends beyond immediate commercial implications and encompasses a broader spectrum of societal and...
Results of the MARIPOSA-2 Study for Advanced Lung Cancer
The latest advancements in cancer treatment are offering new hope to patients with advanced non-small cell lung cancer (NSCLC), especially those with specific genetic mutations. This news report focuses on the MARIPOSA-2 study, an...
Decoding cell fate: Key mechanism in stem cell switch identified
Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation? Using intestinal organoids, the group of Bon-Kyoung Koo...
